Pharmaceutical Development

Pharmaceutical Development
Product Description

Meet customers’ diversified demands for R&D
Provide customers with comprehensive support from R&D to manufacturing, covering multiple dosage form development, including solid preparation (tablets, capsules, granules), liquid preparations (oral solutions, injections), and semi-solid preparations (ointment) etc., meeting the customers’ diversified demands for product development.
Mature and stable technical transfer team
1.R&D aiming at commercial production:Take production into consideration at the project initiation stage, optimize process robustness and reduce costs

2.R&D of multiple dosage form meeting diversified demands:provide customized service for diversified customer demands, support the high-quality production of multiple dosage forms and batch size

3.Mature technical transfer service:100+ commercialization by the team, moving smoothly from R&D to production, ensuring quick and stable product commercialization

Huayi Pharmaceuticals (Anhui) Co.,Ltd

  • Country/Region:
    China
  • On CPHI since:
    2021
  • Certificates:
    2
  • Employees:
    250 - 499
Company types
CMO/CDMO
Contract Service
Specifications
  • Selling Points
    Experienced Technicians

Huayi Pharmaceuticals (Anhui) Co.,Ltd

  • Country/Region:
    China
  • On CPHI since:
    2021
  • Certificates:
    2
  • Employees:
    250 - 499
Company types
CMO/CDMO
Contract Service

More Products from Huayi Pharmaceuticals (Anhui) Co.,Ltd (2)

  • Commercial production

    Product Commercial production

    Various manufacturing processes available and flexible batch sizes.
    Each process is equipped with multiple production function rooms,and each function room adopts an independent HVAC system to minimizecross-contamination during manufacturing of multiple products.

    Capacity: 13 billion tablet...
  • Licensing out

    Product Licensing out

    Licensing out after successful development.

Huayi Pharmaceuticals (Anhui) Co.,Ltd resources (2)

  • News Huayi passed remote GMP re-inspection by MHRA

    On 23rd June, 2021, Huayi passed remote GMP re-inspection by MHRA including new workshops for moderately potency product and oral liquid.
  • Video Huayi Pharmaceuticals

    Huayi Pharmaceutical (Anhui) Co. Ltd. is an EU cGMP approved Sino-British joint venture located in Hefei, Eastern China. We manufacture quality generic medicines on a contractual basis for EU and Chinese customers with competitive pricing.